Related Experiment Video
Updated: Jun 17, 2026

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
Isobolographic Analysis of the Interaction Between Remimazolam and Etomidate in General Anesthesia Induction: A
Wei Yue1, Jiayan Huang2, Qi Wang2
1College of Anesthesiology, Shanxi Medical University and Department of Anesthesiology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Purpose:
This study aimed to investigate the sedative interaction between the new benzodiazepine derivative remimazolam and etomidate during general anesthesia induction and determine the appropriate dose ratio for their combined use.
Patients And Methods:
Patients scheduled for general anesthesia, aged 18 to 60 years with a BMI of 18 to 28 kg/m2 and American Society of Anesthesiologists (ASA) physical status I-II, were randomly divided into five groups using a random number table. The modified Dixon up-and-down method was employed to determine the median effective dose (ED5 0) of remimazolam in Group A (remimazolam group) and etomidate in Group B (etomidate group). For the combined medication groups: Group C (0.25 ED5 0 remimazolam + 0.75 ED5 0 etomidate), Group D (0.5 ED5 0 remimazolam + 0.5 ED5 0 etomidate), and Group E (0.75 ED5 0 remimazolam + 0.25 ED5 0 etomidate), the dose of remimazolam was fixed in each group, and the ED5 0 of etomidate in each group was calculated. Isobolographic analysis was utilized to assess the sedative interaction between the two drugs, and the interaction index and optimal dose ratio for synergism were calculated.
Results:
The ED5 0 of remimazolam and its 95% confidence interval (95% CI) in Group A were 0.193 (0.167-0.253) mg/kg, while those of etomidate in Group B were 0.155 (0.118-0.20) mg/kg. Isobolographic analysis revealed remimazolam and etomidate produced a synergistic effect in Groups C and D, and an additive effect in Group E. When combined at 0.048 mg/kg remimazolam and 0.062 mg/kg etomidate, the optimal dose ratio for the strongest synergism was 1:1.29.
Conclusion:
During general anesthesia induction, when the dose ratios of remimazolam to etomidate are approximately 1:1.29 and 1:0.39, the two drugs exert a synergistic sedative effect, with the strongest synergism observed at the dose ratio of 1:1.29.
More Related Videos
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
07:54Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Related Concept Videos
Stages of General Anesthesia
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...